---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-221971"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2026-05-13T21:20:45+00:00"
generated_at: "2026-05-13T21:30:19.136909+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# vTv Therapeutics upsizes ATM program to maximum authorized shares

## Summary
- Filed a prospectus supplement to increase shares offered under its at-the-market sales program to the full amount authorized.
- The expanded ATM program is under the company's existing shelf registration statement on Form S-3.
- Legal opinion from Dechert LLP on share legality was filed as part of the registration update.

## SEC filing metadata
- accession: 0001193125-26-221971
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2026-05-13T21:20:45+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/0001193125-26-221971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/d72453d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-221971
- JSON: https://secwatch.observer/filing/0001193125-26-221971.json
- Plain text: https://secwatch.observer/filing/0001193125-26-221971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.